Dangerous Synthetic Drug Control Act of 2016 2016-09-26 Passed House amended Dangerous Synthetic Drug Control Act of 2016

(Sec. 2) This bill amends the Controlled Substances Act to add certain synthetic opioids, hallucinogens, and cannabinoids to schedule I. (A schedule I controlled substance is a drug, substance, or chemical that: has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.)

]]> 2015-09-17 Introduced in House Synthetic Drug Control Act of 2015

This bill amends the Controlled Substances Act (CSA) to modify the definition of "controlled substance analogue" to mean a substance that has a similar (previously, substantially similar) chemical structure and pharmacological effect to a schedule I controlled substance.

The CSA's requirements, prohibitions, and restrictions with respect to schedule I controlled substances apply to the manufacture, importation, distribution, and sale (but not possession) of a controlled substance analogue.

The bill amends the Controlled Substances Analogue Enforcement Act of 1986 to add certain synthetic substances to schedule I of the CSA.

]]> text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.